Correction: Targeted therapy in non-small-cell lung cancer—is it becoming a reality?

被引:0
|
作者
F. Janku
D. J. Stewart
R. Kurzrock
机构
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Nat. Rev. Clin. Oncol. 7, 401–414 (2010); doi:10.1038/nrclinonc.2010.64 The last reference in this article, reference 141, is incorrect. The correct reference is US National Library of Medicine. ClinicalTrials.gov [online], (2010).
引用
收藏
页码:384 / 384
相关论文
共 50 条
  • [41] Trimodality therapy for non-small-cell lung cancer
    Roberts, JR
    ONCOLOGY-NEW YORK, 1999, 13 (10): : 101 - 106
  • [42] Maintenance therapy for non-small-cell lung cancer
    Belani, Chandra P.
    Liao, Jason
    LANCET, 2010, 375 (9711): : 281 - 282
  • [43] Reality Check for Pemetrexed and Maintenance Therapy in Advanced Non-Small-Cell Lung Cancer Reply
    Paz-Ares, Luis G.
    de Marinis, Filippo
    Visseren-Grul, Carla
    Gridelli, Cesare
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (05) : 483 - 485
  • [44] Role of molecularly targeted therapy in the management of advanced non-small-cell lung cancer in the elderly
    Rybacka-Chabros, Barbara
    ONCOLOGY IN CLINICAL PRACTICE, 2014, 10 : G52 - G55
  • [45] From radiotherapy to targeted therapy: 20 years in the management of non-small-cell lung cancer
    Weiss, Glen J.
    Bunn, Paul A.
    Dudley, James
    Camidge, D. Ross
    ONCOLOGY-NEW YORK, 2006, 20 (12): : 1515 - 1524
  • [46] Integration of targeted therapy in the management of locally advanced, unresectable non-small-cell lung cancer
    Lo, Ernest
    Daly, Megan E.
    Mack, Philip C.
    Kelly, Karen
    Lara, Primo N., Jr.
    LUNG CANCER MANAGEMENT, 2013, 2 (01) : 75 - 85
  • [47] Recent Developments and Challenges in Molecular-Targeted Therapy of Non-Small-Cell Lung Cancer
    Rohilla, Suman
    Singh, Mahaveer
    Alzarea, Sami I.
    Almalki, Waleed Hassan
    Al-Abbasi, Fahad A.
    Kazmi, Imran
    Afzal, Obaid
    Altamimi, Abdulmalik Saleh Alfawaz
    Singh, Sachin Kumar
    Chellappan, Dinesh Kumar
    Dua, Kamal
    Gupta, Gaurav
    JOURNAL OF ENVIRONMENTAL PATHOLOGY TOXICOLOGY AND ONCOLOGY, 2023, 42 (01) : 27 - 50
  • [48] From radiotherapy to targeted therapy: 20 years in the management of non-small-cell lung cancer
    Weiss, Glen J.
    Bunn, Paul A., Jr.
    Camidge, D. Ross
    ONCOLOGY-NEW YORK, 2006, 20 (14): : 1862 - 1862
  • [49] The eligibility of advanced non-small-cell lung cancer patients for targeted therapy clinical trials
    Clarey, J.
    Kao, S. C.
    Clarke, S. J.
    Vardy, J.
    ANNALS OF ONCOLOGY, 2012, 23 (05) : 1229 - 1233
  • [50] NTRK Fusion-positive Non-small-cell Lung Cancer: The Diagnosis and Targeted Therapy
    Haratake, Naoki
    Seto, Takashi
    CLINICAL LUNG CANCER, 2021, 22 (01) : 1 - 5